Clinical Trial Update: Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and pharmacodynamic effects of BIIB122 in individuals with LRRK2-associated Parkinson's disease; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIIB122

Snippet

Sponsor: Denali Therapeutics Inc. | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING